DMP.F

Healthcare Drug Manufacturers - Specialty & Generic

Dermapharm Holding SE

€37.30
+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap
1.85B
Avg Volume
43
P/E (TTM)
13.32
EPS
€2.80
52W High
€50.70
52W Low
€32.30
Div. Yield
2.4%

Analyst Ratings

Buy
2
Str Buy
2
Buy
2
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
12.57
P/B Ratio
3.43
P/S Ratio
1.56
EV/EBITDA
9.08
EV/Revenue
2.38

Margins

Gross Margin 65.4%
Operating Margin 15.9%
Net Margin 12.4%
EBITDA Margin 26.2%

Growth & Returns

Revenue Growth (YoY)
4.8%
Earnings Growth (YoY)
20.5%
Earnings Growth (QoQ)
11.2%
Return on Equity
25.6%
Return on Assets
7.1%

Liquidity & Leverage

Current Ratio
1.71
Quick Ratio
0.75
Debt / Equity
2.19
Total Cash
195.56M
Total Debt
1.17B

About

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

ir.dermapharm.de